Binod Dhakal, MD
Associate Professor
Locations
- Froedtert Hospital
- Clinical Cancer Center - Froedtert Hospital
Specialties
- Hematology
- Medical Oncology
Languages
- English, Nepali, Hindi
Clinical Cancer Center - Froedtert Hospital
Education
- MD - Doctor of Medicine
Biography
Research Interests
Publications
-
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
(Al Hadidi S, Szabo A, Mohan Lal B, Bag A, Zhen S, Ogunsesan Y, Annyapu E, Dhakal B, Bhutani D, Thanendrarajan S, Zangari M, D'Souza A, Lentzsch S, van Rhee F, Chakraborty R, Schinke C, Mohan M, Shah MR.) Blood Cancer J. 2025 Nov 07;15(1):196 PMID: 41203605 PMCID: PMC12594773 SCOPUS ID: 2-s2.0-105021068508 11/08/2025
-
Molecular and immunological determinants of long-term survival in multiple myeloma.
(Kasomva K, Yadav K, Janz S, Dhakal B, Rao S.) Blood Adv. 2025 Oct 28;9(20):5134-5147 PMID: 40674709 PMCID: PMC12550235 07/17/2025
-
(Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees M, Costello P, Vazquez Martinez M, Pasvolsky O, Wagner C, Davis JA, Castaneda Puglianini O, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo R, Freeman C, Mikkilineni L, Raza S, Anderson LD Jr, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa M, Midha S, Alsina M, Sborov D, Patel K, Lin Y, Ferreri C, Gagelmann N, Kumar A, Hansen D, Cowan A, Costa LJ, Merz M, Sidana S.) Blood. 2025 Oct 23;146(17):2063-2072 PMID: 40749169 SCOPUS ID: 2-s2.0-105014970046 08/01/2025
-
The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia.
(Shrestha A, Thanendrarajan S, Bag A, Dhakal B, Zangari M, Al-Hadidi S, van Rhee F, D'Souza A, Shah N, Shah MR, Mohan M, Schinke C.) Blood Adv. 2025 Oct 14;9(19):4806-4809 PMID: 40674710 PMCID: PMC12494909 SCOPUS ID: 2-s2.0-105017267704 07/17/2025
-
(Henley EC, Liphart HA, Morris KJ, Awoyinka I, Irwin MR, Costanzo ES, Winston D, D'Souza A, Stolley M, Dhakal B, Mohan M, Pasquini MC, Cole SW, Doerwald ES, Bendis PC, Rentscher KE, Rumble ME, Szabo A, Rao S, Knight JM.) Contemp Clin Trials Commun. 2025 Oct;47:101540 PMID: 40893725 PMCID: PMC12397865 09/02/2025
-
(Touzeau C, Lipe B, Khan AM, Dhakal B, Nair S, He J, Mendes J, Lee S, Lonardi C, Slaughter A, Lendvai N, Schecter JM, Chen D, Zhao M, Yeh TM, Leleu X, Puig N, Dytfeld D, Zamagni E, Weisel K, Karlin L, Delforge M, Corradini P, Mina R, Roeloffzen W, Sidana S.) Adv Ther. 2025 Oct;42(10):5023-5041 PMID: 40768190 PMCID: PMC12474644 SCOPUS ID: 2-s2.0-105012841831 08/06/2025
-
(Yadav K, Mohan M, Wagner C, Chakraborty R, Sborov D, Godara A, McClune B, Schinke C, Dhakal B, D'Souza A, Szabo A, Mohyuddin GR.) Leukemia. 2025 Sep;39(9):2289-2291 PMID: 40670671 SCOPUS ID: 2-s2.0-105011037613 07/17/2025
-
(Galarza Fortuna GM, Peres LC, Nazarenko E, De Menezes Silva Corraes A, Hovanky V, Shune L, McGuirk JP, de Avila G, Khouri J, Dima D, Gaballa MR, Dhakal B, Forsberg PA, Godara A, Afrough A, Anderson LD Jr, Herr MM, Davis JA, Mann H, Purvey S, Clark WB, Htut MM, Beitinjaneh AM, Pereira DL, Kocoglu M, Ferreri CJ, Atrash S, Voorhees PM, Rossi AC, Richard S, Hashmi H, Patel KK, Sidana S, Lin Y, Hansen DK, Sborov DW.) Blood Adv. 2025 Aug 28 PMID: 40875887 08/28/2025
-
(Vandenboom H, Akhtar O, Szabo A, Narra R, Mohan M, D'Souza A, Pasquini M, Dhakal B.) Haematologica. 2025 Aug 14 PMID: 40820831 08/18/2025
-
(Ailawadhi S, Anderson LD Jr, Dhakal B, Shune L, Sborov DW, Hansen DK.) Clin Lymphoma Myeloma Leuk. 2025 Aug 07 PMID: 40885679 08/31/2025
-
(Dhakal B, Einsele H, Schecter JM, Deraedt W, Lendvai N, Slaughter A, Lonardi C, Nair S, Varghese NE, He J, Kharat A, Lee S, Cost P, Potluri R, Koneru M, Patel N, Florendo E, Rodriguez-Otero P, Yong K.) Cancer Med. 2025 Aug;14(15):e71093 PMID: 40719208 PMCID: PMC12301936 SCOPUS ID: 2-s2.0-105011846353 07/28/2025
-
(Henley EC, Liphart HA, Morris KJ, Awoyinka I, Irwin MR, Costanzo ES, Winston D, D'Souza A, Stolley M, Dhakal B, Mohan M, Pasquini MC, Cole SW, Doerwald ES, Bendis PC, Rentscher KE, Rumble ME, Szabo A, Rao S, Knight JM.) Contemporary Clinical Trials Communications. October 2025;47 SCOPUS ID: 2-s2.0-105013637528 10/01/2025